Business Wire

Esri’s ArcGIS Basemaps Power Dataminr First Alert for Enhanced Real-Time Event Detection and Awareness

14.7.2025 14:00:00 CEST | Business Wire | Press Release

Share

Esri, the global leader in location intelligence, has partnered with Dataminr, the leading real-time AI platform, to enhance real-time emergency response for public organizations. Esri’s ArcGIS Basemaps will be integrated into Dataminr First Alert, a real-time critical event discovery solution. Used by public sector organizations around the globe for emergency and crisis response, diplomatic security, infrastructure protection, and more, First Alert will leverage Esri’s ArcGIS Basemaps to improve decision-making for customers. Over the next few months, Dataminr will transition current First Alert users to the new Esri basemap experience.

“By equipping First Alert users with Esri’s comprehensive and authoritative collection of basemaps, we are happy to empower organizations with the advanced geospatial awareness that only our location services can provide,” said Richard Cooke, Corporate Director of Global Business Development at Esri. “This integration will enable Dataminr customers to detect emerging threats earlier, visualize their proximity to critical assets, and make faster, more informed decisions.”

This new integration enables a single map-based operations resource for users who need real-time understanding of events and potential emergencies. By combining the power of mapping with AI, it will allow users to detect and locate emerging risks and events to provide the earliest possible warning significantly faster than traditional methods. Enhanced mapping performance and visual context enable accelerated understanding and decision-making.

“With Esri’s geospatial data as a foundation for First Alert’s operational picture, we’re creating a new standard for how the public sector manages and contextualizes risk through real-time, actionable insights,” said Brian Gumbel, President and Chief Operating Officer at Dataminr. "When minutes matter, knowing exactly what's happening, and where, is the key to an effective response."

Serving government and public safety organizations across more than 220 countries and territories, Dataminr is recognized as one of the world’s leading AI software providers. The company’s unique platform monitors more than one million public data sources, including images, video, and text in over 150 languages. Dataminr will begin migrating existing customers to ArcGIS Basemaps, with the transition to be complete by the end of the year. However, customers who would like to accelerate full access to Esri’s basemaps can reach out to their Customer Success Manager to initiate the process.

Public sector organizations can also learn more about integrating Dataminr's real-time AI platform into their existing Esri ArcGIS environment by reaching out to esri@dataminr.com.

To learn more about how Esri’s world-leading maps and location services can enhance real-time awareness and decision-making, visit esri.com/en-us/arcgis/products/arcgis-location-platform/overview.

About Dataminr

Dataminr has created a revolutionary real-time AI platform for detecting events, risks, and critical information from public data signals. The company’s world-leading AI platform performs trillions of daily computations across billions of public data inputs from more than one million unique public data sources. Dataminr is known for its trailblazing AI platform, which pioneered Multi-Modal Fusion AI—synthesizing terabytes of real-time data spanning text, image, video, sound, and sensor signals for accurate, real-time event, threat and risk detection across 150+ languages and 220+ countries and territories. The company also pioneered ReGenAI, a breakthrough form of Gen AI that automatically regenerates live event briefs in real time as events unfold. Powered by more than 50 proprietary large-language models, Dataminr delivers the earliest actionable information to enhance the security and resilience of organizations, infrastructure, and people. For more information, visit www.dataminr.com.

About Esri

Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in hundreds of thousands of organizations globally, including Fortune 500 companies, government agencies, nonprofit institutions, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial technology and analytics, Esri engineers the most innovative solutions that leverage a geographic approach to solving some of the world’s most complex problems by placing them in the crucial context of location. Visit us at esri.com.

Copyright © 2025 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250714902883/en/

Contacts

Jo Ann Pruchniewski
Public Relations, Esri
Mobile: 301-693-2643
Email: jpruchniewski@esri.com

Dataminr Media Relations
media@dataminr.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye